Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.

World Journal of Gastroenterology : WJG
Vasiliki PsofakiGeorgios Kolios

Abstract

To investigate aberrant DNA methylation of CpG islands and subsequent low- or high-level DNA microsatellite instability (MSI) which is assumed to drive colon carcinogenesis. DNA of healthy individuals, adenoma (tubular or villous/tubulovillous) patients, and colorectal carcinoma patients who underwent colonoscopy was used for assessing the prevalence of aberrant DNA methylation of human DNA mismatch repair gene mutator L homologue 1 (hMLH1), Cyclin-dependent kinase inhibitor 2A (CDKN2A/p16), and O-6-methylguanine DNA methyltransferase (MGMT), as well as their relation to MSI. The frequency of promoter methylation for each locus increased in the sequence healthy tissue/adenoma/carcinoma. MGMT showed the highest frequency in each group. MGMT and CDKN2A/p16 presented a statistically significant increase in promoter methylation between the less and more tumorigenic forms of colorectal adenomas (tubular vs tubullovillous and villous adenomas). All patients with tubulovillous/villous adenomas, as well as all colorectal cancer patients, showed promoter methylation in at least one of the examined loci. These findings suggest a potentially crucial role for methylation in the polyp/adenoma to cancer progression in colorectal carcinogenes...Continue Reading

References

Mar 5, 1992·The New England Journal of Medicine·W S AtkinJ Cuzick
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·M L VeiglS D Markowitz
Apr 30, 1999·Gastroenterology·R J GuanA B Pardee
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Nov 30, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M Esteller
Apr 2, 2004·Gastroenterology·M E MartínezD S Alberts
Sep 11, 2001·The American Journal of Pathology·A RashidS R Hamilton
May 10, 2002·The American Journal of Pathology·Annie On-On ChanAsif Rashid
Jul 27, 2002·Annual Review of Genomics and Human Genetics·William M Grady, Sanford D Markowitz
Feb 25, 2003·The American Journal of Pathology·Seun-Ja ParkTsung-Teh Wu
Mar 26, 2003·The American Journal of Pathology·Carolyn BariolRobyn Ward
May 4, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Sun LeeGyeong Hoon Kang
Dec 2, 2004·Nature Reviews. Cancer·Jean-Pierre Issa
Feb 5, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F LoeveJ D F Habbema
Dec 13, 2005·Journal of Gastroenterology and Hepatology·Hee Cheol KimJin Cheon Kim

❮ Previous
Next ❯

Citations

Sep 20, 2012·International Journal of Colorectal Disease·Seung-Chul PackSoong Lee
Oct 23, 2012·Molecular Biology Reports·Ewa BrzeziańskaAdam Antczak
Nov 19, 2011·Applied Immunohistochemistry & Molecular Morphology : AIMM·Imen Miladi-AbdennadherRaja Mokdad-Gargouri
Jul 30, 2011·World Journal of Gastroenterology : WJG·Ferenc SiposZsolt Tulassay
Aug 16, 2014·Biochemical and Biophysical Research Communications·Timothy M Barrow, Karin B Michels
Jul 11, 2014·World Journal of Gastroenterology : WJG·Xue-Yuan CaoJing Jiang
May 9, 2014·Gastroenterology Research and Practice·Winnie C FernandoKevin J Spring
Jan 13, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·S VeganzonesE Díaz-Rubio
Jan 22, 2011·The Korean Journal of Hematology·Sun-Young KimJong-Jin Seo
Apr 25, 2015·Experimental Biology and Medicine·Christina MichailidiConstantinos Troungos
Mar 17, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Pooneh MokarramMahvash Alizade Naini
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·M Alizade NainiM Borji
Apr 25, 2018·Cancer Biomarkers : Section a of Disease Markers·Giuseppe LatiniGiorgio Bianciardi
Dec 12, 2012·Experimental and Therapeutic Medicine·Ebru Esin YorukerNejat Dalay
May 10, 2020·International Journal of Molecular Sciences·Anna SiskovaVeronika Vymetalkova
Nov 24, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I C BarısV Caner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Alfa H C BaiWai K Leung
Neoplasia : an International Journal for Oncology Research
Matthias P A EbertCatherine Lofton-Day
© 2021 Meta ULC. All rights reserved